Atlas Trials

Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults

Clinical trial NCT04386252 · WITHDRAWN

Trial details

NCT number
NCT04386252
Sponsor
Aivita Biomedical, Inc.
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2023-01-01
Primary completion
2023-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.